chrX-38367418-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000531.6(OTC):c.205C>T(p.Gln69*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000531.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTC | NM_000531.6 | c.205C>T | p.Gln69* | stop_gained | Exon 2 of 10 | ENST00000039007.5 | NP_000522.3 | |
OTC | NM_001407092.1 | c.205C>T | p.Gln69* | stop_gained | Exon 4 of 12 | NP_001394021.1 | ||
OTC | XM_017029556.2 | c.205C>T | p.Gln69* | stop_gained | Exon 2 of 9 | XP_016885045.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTC | ENST00000039007.5 | c.205C>T | p.Gln69* | stop_gained | Exon 2 of 10 | 1 | NM_000531.6 | ENSP00000039007.4 | ||
ENSG00000250349 | ENST00000465127.1 | c.172-298703C>T | intron_variant | Intron 3 of 8 | 5 | ENSP00000417050.1 | ||||
OTC | ENST00000488812.1 | n.297C>T | non_coding_transcript_exon_variant | Exon 2 of 6 | 5 | |||||
OTC | ENST00000643344.1 | n.205C>T | non_coding_transcript_exon_variant | Exon 2 of 11 | ENSP00000496606.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 27
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Pathogenic:2
- -
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 97133). This premature translational stop signal has been observed in individual(s) with ornithine transcarbamylase deficiency (PMID: 10502831). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln69*) in the OTC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OTC are known to be pathogenic (PMID: 10946359, 16786505). -
not provided Pathogenic:2
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at